Exclusion criteria:
Dermatitis, skin loss, incontinence
HAND INFECTION, INCONTINENCE, INCONTINENCE, DERMATITIS, FAECAL INCONTINENCE, PAD
These include residents who:
have frequent (daily) faecal incontinence (FI) in the pad or have severe problems with FI as determined by the study investigatorhave a life expectancy of fewer than 3 months, in the opinion of the resident’s physician of record, or be in receipt of palliative/terminal carehave severe continence product-related skin problems, as defined by the Ghent Global Incontinence Associated Dermatitis (GLOBIAD) categorization 2B (skin loss and infection) [have an indwelling or external urinary catheter, or anuriaare managed using another automated or digital health technology incontinence management devicehave responsive behaviours of sufficient severity, in the opinion of the care staff, to make participation impractical as judged by the investigator, have any other condition that makes participation in the clinical investigation inappropriatehave participated in an investigational study of a drug, biologic or device within 30 days prior to entering the clinical investigation or planned during the clinical investigationare dependent on either alcohol or recreational drugs